Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version
Luis Pino,
Carlos Perez,
Andres Cardona,
Ivan Triana
Affiliations
Luis Pino
Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia
Carlos Perez
Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia
Andres Cardona
Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia
Ivan Triana
Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia